Clinical trials
Vasomotor Symptoms (VMS) clinical trials
Below are recruiting vasomotor symptoms (vms) clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06957691RecruitingPhase 2
Fezolinetant for hot flashes in men on hormone therapy
This study tests a medication called fezolinetant to see if it reduces hot flashes in men undergoing hormone therapy for prostate cancer. If you experience frequent hot flashes, this treatment might help alleviate them.
Boston, MassachusettsAges 40 years+ - NCT07042516RecruitingPhase 2
Asimadoline for hot flashes in women going through menopause
This study tests if asimadoline can safely reduce hot flashes and night sweats in menopausal or late perimenopausal women. You must not be on any medications for hot flashes currently.
Atlanta, GeorgiaAges 40–62 - NCT07033013Recruiting
Study of an oral supplement for menopause hot flashes
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
San Francisco, CaliforniaAges 40–65 - NCT07511660Enrolling by invitation
Ovarian cell injection for perimenopause symptom relief
This trial tests injecting special cells called Muse cells into the ovaries to help relieve perimenopause symptoms and possibly restore ovarian function. It may help women experiencing irregular periods, hot flashes, sleep problems, mood changes, or trouble thinking clearly.
Monterrey, Nuevo LeónAges 28–70 - NCT06976112Recruiting
Lean pork and heart health in perimenopause
This study tests whether adding lean pork to your diet can improve blood vessel function during perimenopause. You may be eligible if you are a woman between 40 and 55, have irregular periods, and have high blood pressure but not diabetes.
Baton Rouge, LouisianaAges 40–55 - NCT07535541Recruiting
Smartwatch Study of Hot Flashes in Prostate Cancer Patients
This study tests whether a smartwatch can accurately measure hot flashes (sudden heat and sweating) that occur in men undergoing hormone therapy for prostate cancer. You'll wear the smartwatch for about 4 weeks while the research team tracks your symptoms.
Charlottesville, VirginiaAges 18 years+ - NCT06917313RecruitingPhase 2
Fezolinetant for hot flashes in women with breast cancer on hormone therapy
This trial tests a drug called fezolinetant to see if it reduces hot flashes in women with HR+ breast cancer who are on hormone therapy (like tamoxifen or aromatase inhibitors). You need to be postmenopausal and having at least 7 moderate to severe hot flashes a day.
New Haven, ConnecticutAges 18 years+
Hear when a new Vasomotor Symptoms (VMS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for vasomotor symptoms (vms)?
- Yes. Clin2 currently lists 7 recruiting vasomotor symptoms (vms) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a vasomotor symptoms (vms) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a vasomotor symptoms (vms) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.